Literature DB >> 13214379

Mental depression in hypertensive patients treated for long periods with large doses of reserpine.

E D FREIS.   

Abstract

Entities:  

Keywords:  DEPRESSION/etiology and pathogenesis; HYPERTENSION/therapy; RAUWOLFIA

Mesh:

Substances:

Year:  1954        PMID: 13214379     DOI: 10.1056/NEJM195412162512504

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  64 in total

Review 1.  [Reserpine-diuretic combinations in therapy of arterial hypertension. Current considerations].

Authors:  M Siepmann; W Kirch
Journal:  Med Klin (Munich)       Date:  1998-12-15

2.  Reserpine-a comparison of chronic toxicity in animals with clinical toxicity.

Authors:  J M PARKER; C W MURPHY
Journal:  Can Med Assoc J       Date:  1961-05-27       Impact factor: 8.262

3.  Mental depressive episodes during Rauwolfia therapy for arterial hypertension, with special reference to dosage.

Authors:  E BOLTE; J MARC-AURELE; J BROUILLET; P BEAUREGARD; M VERDY; J GENEST
Journal:  Can Med Assoc J       Date:  1959-02-15       Impact factor: 8.262

4.  A clinical evaluation of antihypertensive drugs.

Authors:  I H PAGE
Journal:  Bull N Y Acad Med       Date:  1957-04

5.  Rauwolfia serpentina in the control of anxiety.

Authors:  P LOWINGER
Journal:  Psychiatr Q       Date:  1957-07

6.  Use of reserpine and Rauwolfia in psychoneuroses.

Authors:  A FOLKSON; A R MAY
Journal:  Br Med J       Date:  1955-11-05

7.  Trial of reserpine in treatment of schizophrenia.

Authors:  E A MARTIN; J N MOORE
Journal:  Br Med J       Date:  1957-01-05

8.  Depressive states during Rauwolfia therapy for arterial hypertension; a report of 30 cases.

Authors:  G LEMIEUX; A DAVIGNON; J GENEST
Journal:  Can Med Assoc J       Date:  1956-04-01       Impact factor: 8.262

9.  [New drugs for the management of hypertension].

Authors:  R W GIFFORD
Journal:  Klin Wochenschr       Date:  1956-01-15

10.  Psychosis and enhanced anxiety produced by reserpine and chlorpromazine.

Authors:  G J SARWER-FONER; W OGLE
Journal:  Can Med Assoc J       Date:  1956-04-01       Impact factor: 8.262

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.